163 related articles for article (PubMed ID: 16434892)
21. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
22. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.
Lin JY; Li XY; Dong P; Nakashima T
J Laryngol Otol; 2011 Sep; 125(9):945-51. PubMed ID: 21774849
[TBL] [Abstract][Full Text] [Related]
24. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
25. Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancer.
Audet N; Beasley NJ; MacMillan C; Jackson DG; Gullane PJ; Kamel-Reid S
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1065-70. PubMed ID: 16365219
[TBL] [Abstract][Full Text] [Related]
26. Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation.
de Sousa EA; Lourenço SV; de Moraes FP; Vartanian JG; Gonçalves-Filho J; Kowalski LP; Soares FA; Coutinho-Camillo CM
Head Neck; 2015 Oct; 37(10):1410-6. PubMed ID: 24824527
[TBL] [Abstract][Full Text] [Related]
27. D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness.
Minardi D; d'Anzeo G; Lucarini G; Filosa A; Zizzi A; Simonetti O; Polito M; Offidani AM; Di Primio R; Montironi R; Muzzonigro G
Hum Pathol; 2011 Nov; 42(11):1596-602. PubMed ID: 21497368
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of dysadherin expression in advanced colorectal carcinoma.
Aoki S; Shimamura T; Shibata T; Nakanishi Y; Moriya Y; Sato Y; Kitajima M; Sakamoto M; Hirohashi S
Br J Cancer; 2003 Mar; 88(5):726-32. PubMed ID: 12618882
[TBL] [Abstract][Full Text] [Related]
29. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S
Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504
[TBL] [Abstract][Full Text] [Related]
30. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
31. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
[TBL] [Abstract][Full Text] [Related]
33. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium.
Irjala H; Alanen K; Grénman R; Heikkilä P; Joensuu H; Jalkanen S
Cancer Res; 2003 Aug; 63(15):4671-6. PubMed ID: 12907648
[TBL] [Abstract][Full Text] [Related]
34. Understanding patterns of invasion: a novel approach to assessment of podoplanin expression in the prediction of lymph node metastasis in oral squamous cell carcinoma.
Sharma A; Boaz K; Natarajan S
Histopathology; 2018 Mar; 72(4):672-678. PubMed ID: 29023936
[TBL] [Abstract][Full Text] [Related]
35. Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma.
Wakisaka N; Yoshida S; Kondo S; Kita M; Sawada-Kitamura S; Endo K; Tsuji A; Nakanish Y; Murono S; Yoshizaki T
Histopathology; 2015 May; 66(6):771-80. PubMed ID: 25039283
[TBL] [Abstract][Full Text] [Related]
36. LTBP2 is a prognostic marker in head and neck squamous cell carcinoma.
Han L; Tang MM; Xu X; Jiang B; Huang J; Feng X; Qiang J
Oncotarget; 2016 Jul; 7(29):45052-45059. PubMed ID: 27281608
[TBL] [Abstract][Full Text] [Related]
37. Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer.
Georgolios A; Eleftheriadou A; Batistatou A; Charalabopoulos K
Med Oncol; 2012 Sep; 29(3):1463-7. PubMed ID: 22105147
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
[TBL] [Abstract][Full Text] [Related]
39. Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases.
Andrews NA; Jones AS; Helliwell TR; Kinsella AR
Br J Cancer; 1997; 75(10):1474-80. PubMed ID: 9166940
[TBL] [Abstract][Full Text] [Related]
40. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]